Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
16/10/2026 02:19
BRIEF-Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre Oct 16 (Reuters) - Algorae Pharmaceuticals Ltd 1AI.AX:
PARTNERS WITH PETER MACCALLUM CANCER CENTRE FOR THIRD AI-DRIVEN DRUG SYNERGY SCREENING PROGRAM
Further company coverage: 1AI.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative